Ada's clinical AI helps patients understand their symptoms, identifies likely conditions, and guides them toward the most appropriate next steps in their care journey.
Reduce barriers to diagnosis
Leverage safe and clinically validated AI-based tools to expand your brand’s reach to undiagnosed, hard-to-reach, or unique patients.
Speed up treatment and drive ROI
Amplify your marketing investment, increasing launch impact and prescription growth.
Engage elibible patients
Provide convenient end-to-end digital care journeys for patients with specific conditions.
Engage symptomatic, undiagnosed, or on-treatment patients earlier in their care journey through high-performing acquisition tactics.
Offer patients clinically validated self-assessments and personalized guidance to appropriate care.
Help patients access the care, diagnosis, and therapy they need.
Millions of patients engage with Ada because of our deep clinical expertise and experience. They tell us all about their health and lifestyle. In return, we help them learn and navigate their way toward positive health outcomes.
Ada is the world’s leading AI-powered symptom assessment and care navigation platform, developed by doctors. With 13 years of research and development, Ada analyzes billions of symptom patterns to deliver accurate and safe advice.
Ada’s fully explainable AI is designed to mimic a doctor’s reasoning. Our approach to safety, efficacy, and scientific scrutiny earns us the trus of clinicians and patients (1)
93%
of patients said Ada asked questions that their doctor wouldn’t have considered
83%
of Ada’s top suggestions match a physician’s final diagnosis
97%
advice accuracy, comparable to human physicians
99.5%
of Ada’s advice is safe
Partners value our commitment to regulation and quality management
EU-MDR
Class IIa Regulated Medical Device
US Food and Drug Administration
Ada operates under FDA enforcement discretion
HIPPA Compliant
US Health Insurance Portability and Accountability Act
ISO 13485
Certified quality management system
Connected digital health initiatives are a key step in lower cost, faster, more equitable, and more convenient access to healthcare… We are excited to be a part of this COVID-19 Care Journey and for its potential to help reach some of the most vulnerable patients across the United States
Our shared goal is to enable anyone to take more ownership of their health via credible, science-based information delivered through products they know and can rely on.
Our collaboration with Ada is designed to educate patients on high-risk factors for severe COVID-19 and introduce choices for people to access a provider and learn about treatment options.
Ada is a great mechanism for consumers to really critically assess and understand their symptoms and get clarity on what conditions they might be suffering from.
Launch of a nationwide online COVID-19 Care Journey, operated by Ada, to help connect patients with timely treatment.
Exploring the impact of AI on stigmatized women's health conditions.
Read about one of Bayer's projects with Ada.
93%: Real-world research of patients and clinicians in Africa (2023);
83%: Client data from Ada's active post-market surveillance (2023);
97%: Gilbert et al. (2020), BMJ Open;
99%: Zangzhu, Z., et al. (2023), Chinese Journal of General Practicitioners.
